1. GBp

    4,285

    Today's change

    46.50 / +1.10%

    1 year change

    +33.74%

    As of Aug 20 2014 17:07 BST. Data delayed by at least 15 minutes.

Search for AstraZeneca PLC and
  1. NEW

    3:49PM

    What next for M&A now the bubble has burst?

    Tuesday August 5 was a bad day for all those hoping the mergers and acquisitions boom had further to run. Investment bankers...

  2. August 19, 2014

    DoJ closes AstraZeneca probe without bringing charges

    US authorities have closed a 10-month investigation into contentious drug trial data surrounding an important AstraZeneca...

Special Reports

  1. 50 Top Business Ideas

    The FT puts the spotlight on which inventions and innovations have helped to create to...
  2. Engineering the Future

    Many of the world’s most exciting companies have engineering innovation at their heart...
Search more Special Reports on this topic.

  1. August 19, 2014

    AstraZeneca tops FTSE 100

    AstraZeneca made the best single gain on the FTSE 100 on Tuesday after the drug company welcomed news that the US...

  2. August 7, 2014

    Viking raiders will bring Norse sense to company votes

    “From the wrath of the Northmen, oh lord, deliver us,” were the words gabbled by Dark Age peasants in hopes of warding off...

  3. August 6, 2014

    Pharma shares slide on fears of ‘tax inversion’ clampdown

    Investors fled global healthcare stocks on Wednesday after the Obama administration threatened action to halt the wave of...

  4. August 6, 2014

    FTSE 100 bid stocks lead broad losses

    Stocks at the centre of recent bid activity faltered on the FTSE 100 on Wednesday, as jitters spread from news overnight of...

  5. August 5, 2014

    Corporate acquirors take early aim at their target’s investors

    To win investor support for last month’s $53bn takeover of rival drugmaker Shire, AbbVie delivered a blunt message to its...

  6. August 4, 2014

    High cost to AstraZeneca independence

    The cost of AstraZeneca remaining independent may be greater than investors think, according to Barclays analysts. The...

  7. August 4, 2014

    Bristol-Myers Squibb in venture to turn US research into drugs

    Allied Minds, a Boston-based science and technology development company, has joined forces with biopharmaceutical giant...

  8. August 4, 2014

    AstraZeneca chairman Leif Johansson defends Pfizer rebuff

    Leif Johansson wants to set something straight: he does not want to be prime minister of Sweden. This was just one of the...

  9. August 3, 2014

    Europe delivers earnings growth for the first time in three years

    For the first time in three years, Europe’s companies are delivering earnings growth. But the good news risks being...

  10. July 31, 2014

    AstraZeneca raises full-year earnings guidance

    AstraZeneca raised its full-year earnings guidance on Thursday as Pascal Soriot, chief executive, declared “significant...

  11. July 30, 2014

    AstraZeneca to bolster respiratory drugs with Almirall deal

    AstraZeneca has bought a range of respiratory drugs from Almirall of Spain for up to $2.1bn in its biggest deal since...

  12. July 22, 2014

    US warned of up to 25 groups eyeing foreign switch to cut tax

    Up to 25 more US companies are considering relocating overseas to cut their tax bills this year, a Democratic senator has...

  13. July 18, 2014

    AstraZeneca unveils plans for £330m R&D centre in Cambridge

    AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May. Two...

  14. July 16, 2014

    Eli Lilly joins forces with UK biotech to develop cancer drugs

    Eli Lilly has entered the race to develop a new generation of oncology drugs, which harness the immune system to kill cancer...

  15. July 16, 2014

    David Cameron moves to boost UK life sciences

    The appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s...

  16. July 14, 2014

    AbbVie/Shire - join us at 12 for a live discussion

    The above is a clause from the Medtronic/Covidien merger agreement of course – although it allows Medtronic to walk away...

  17. July 13, 2014

    Vince Cable plans to toughen up takeover rules

    Vince Cable plans to strengthen Britain’s takeover rules to make it harder for international bidders to renege on promises...

  18. July 8, 2014

    Cable backtracks on move to protect science industry

    Vince Cable has signalled the coalition will resist the Labour party’s demands for stronger government powers to intervene...

  19. July 8, 2014

    AbbVie avoids Pfizer errors in bear hug against Shire

    My pals are bigger than your pals. AbbVie has resorted to an old playground intimidation tactic, by implying a majority of...

  20. July 7, 2014

    Woodford goes big on AstraZeneca in new fund

    Neil Woodford, one of Britain’s most celebrated fund managers, has revealed that drugmaker AstraZeneca is the largest...

  21. July 2, 2014

    Drug groups welcome UK push to tackle superbugs

    Drugmakers have welcomed the appointment of Jim O’Neill, the former Goldman Sachs chief economist, to lead a UK...

  22. July 1, 2014

    AstraZeneca chief increases stake in drugmaker

    AstraZeneca’s chief executive has signalled his confidence in the company’s prospects by buying £2m worth of its shares,...

  23. June 29, 2014

    Global dealmaking shows return to vigour

    It was with qualified optimism that Ian Read, Pfizer’s chief executive, boarded his private jet to London on the penultimate...

  24. Business Blog

    June 27, 2014

    Defensive play in the World Cup of corporate taxation

    The global system for taxing multinational companies is broken, but no country wants to alter it too radically for fear of...

  25. June 26, 2014

    Not all AGM protests are centred on executive pay

    Exactly a year ago, Li Ruigang was one of the most unpopular directors at any FTSE 100 company – at least as far as...

  26. June 20, 2014

    AstraZeneca set to bolster takeover defences

    AstraZeneca is considering selling the rights to some of its future revenues in a move that would boost the UK drugmaker’s...

  27. June 18, 2014

    David Cameron launches world’s biggest dementia study

    The world’s biggest study of dementia will be unveiled by David Cameron on Thursday as part of a push worth more than £100m...

  28. June 17, 2014

    Major pharmaceutical groups may be too big to succeed

    As Pfizer eyed a £70bn takeover of AstraZeneca this spring, the prospective deal highlighted an awkward truth for the chief...

  29. June 16, 2014

    UK biotech groups’ rush to market injects sense of optimism

    Britain’s biotech sector has experienced more false dawns than most industries. But after a barren decade, a series of deals...

  30. June 15, 2014

    Time moves slowly for biotech investors

    Scientists are supposed to alight upon miraculous cures in a eureka moment. But, in reality, it usually takes years to make...

  31. June 12, 2014

    AstraZeneca in $232m asthma drug deal

    AstraZeneca has struck a deal worth up to $232m with a UK biotech company to develop a new asthma drug, highlighting its...

  32. June 11, 2014

    A new approach is needed for British dealmaking

    Many countries have liberalised their takeover regimes in the past three decades. Thanks to this and the impact of...

  33. June 10, 2014

    Better life for insurers as pensions megadeals take off

    Another month, another pensions insurance megadeal. Total this week unveiled an agreement to insure three-fifths of its...

  34. June 8, 2014

    Japanese drugmakers sit out global M&A party

    Japanese drugmakers have been conspicuous by their absence from the dealmaking bonanza sweeping the sector across Europe and...

  35. MBA blog

    June 4, 2014

    The siren song of innovation revisited

    The last few weeks have been busy with learning all about mergers and acquisitions and international finance as a part of my...

  36. June 3, 2014

    AstraZeneca seeks to bring new cancer drugs to market

    AstraZeneca claims to have demonstrated the potential “to transform the way cancer is treated” as it steps up efforts to...

  37. June 3, 2014

    Loan caps too weak to curb runaway London prices

    The correlation between proliferating property porn and rising London house prices cannot have escaped the notice of Royal...

  38. June 2, 2014

    Top pay at FTSE 100 groups still rising despite restraint rules

    Executive pay at the UK’s biggest companies is still rising despite new rules intended to encourage pay restraint, according...

Search for AstraZeneca PLC and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on the rejection of Pfizer's ‘final’ bid...
    May 19, 2014

    Lex on the rejection of Pfizer's ‘final’ bid

  2. The FT debates Pfizer's takeover bid for AstraZeneca...
    May 13, 2014

    The FT debates Pfizer's takeover bid for AstraZeneca

  3. CEO Pascal Soriot on AstraZeneca's move to Cambridge...
    July 3, 2013

    CEO Pascal Soriot on AstraZeneca's move to Cambridge